21 CFR Part 862 · Clinical Chemistry and Clinical Toxicology Devices

§ 862.3220 Carbon monoxide test system

Subpart D - Clinical Toxicology Test Systems Official text on eCFR Amendment history

(a) Identification. A carbon monoxide test system is a device intended to measure carbon monoxide or carboxyhemoglobin (carbon monoxide bound to the hemoglobin in the blood) in blood. Measurements obtained by this device are used in the diagnosis and treatment of or confirmation of carbon monoxide poisoning.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9 .

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

Warning letters citing § 862.3220

1 FDA warning letters since 2017 cite this section :

Amendment history

Federal Register documents that created or amended this section.